Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

Summary

This phase II trial is studying how well dasatinib works in treating patients with advanced liver cancer that cannot be removed by surgery. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2007-04

Primary completion

2011-04

Completion

2011-04

Outcome

Outcome not reported

Stopped: “Halted early for futility.”

Drugs

Indications